跳至主要内容
临床试验/NCT03140150
NCT03140150终止不适用

Safety Acceptability and Benefits of Tracking Cardiac Pacemakers by Carelink Express

University Hospital, Brest4 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年12月26日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
50
试验地点
4
主要终点
At least one unnecessary consultation during two years of follow-up

研究概览

简要总结

Follow-up strategy for patients implanted with a pacemaker.

详细描述

This study seeks to verify that a follow-up strategy for patients implanted with a mono- or double-chamber pacemaker, stimuli-dependent or not, for 2 years, by means of data transmissions of the devices by Carelink Express during the usual consultations with the treating cardiologist significantly reduces the number of unnecessary consultations in the implant centers (without any change in treatment or pacemaker programming) compared to the usual follow-up mode recommended for this type of device.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any patient implanted with a Medtronic brand AAI (R), VVI (R) and DDD (R) cardiac pacemaker, allowing transmission via Carelink Express (Medtronic)
  • and accepting inclusion in the study.
  • The patient should be followed by a city cardiologist participating in the study.

排除标准

  • Age <18 years
  • Pregnant or likely to become pregnant during the study
  • Patient with an unstable medical condition, NYHA Class IV Heart Failure
  • Presence of psychiatric illness, depression, anxiety disorder
  • Presence of diseases, other than heart disease, responsible for a reduction in life expectancy for the duration of the study.
  • Patient unable to follow protocol (respond to questionnaires)
  • Change of residence planned during the study
  • Participation in an interventional and therapeutic clinical study; Patient participation in an observational study is permitted.
  • Patient not signed consent form
  • Patient under legal protection

结局指标

主要结局

At least one unnecessary consultation during two years of follow-up

时间窗: 2 years

The primary outcome measure will be at least one unnecessary consultation during two years of follow-up (apart from the first mandatory consultation in all patients)

次要结局

  • Occurrence of a serious adverse event(2 years)
  • In-depth sociological study carried out through questionnaires and individual interviews(2 years)
  • Quality of life(2 years)
  • The medical economic evaluation to measure the efficiency of the device Carelink Express allowing patients' tele-monitoring implanted by a pacemaker(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Safety Acceptability and Benefits of Tracking... | 临床试验